| Dr Frederick Oehrlein, MD | |
|
2122 Manchester Expy, Columbus, GA 31904-6878 | |
| (706) 596-4000 | |
| Not Available |
| Full Name | Dr Frederick Oehrlein |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 2122 Manchester Expy, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508820960 | NPI | - | NPPES |
| 002784 | Other | GA | STATE BENEFIT PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | DO NOT KNOW NUMBER (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Columbus Pa | 6901701135 | 26 |
| Concordia Anesthesiology Inc | 8325172885 | 62 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published in the July 22, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Angiotech Pharmaceuticals, Inc. today announced that its subsidiary, Angiotech Pharmaceuticals, Inc., has executed a Settlement and License Termination Agreement with Rex Medical, LP, providing for the full and final settlement and/or dismissal of all claims arising under the the License, Supply, Marketing and Distribution Agreement between Angiotech US and Rex, dated March 13, 2008.
Researchers wondered if pay-for-performance (P4P) programs, which reward hospitals for meeting quality targets, have unintentional effects on racial and/or ethnic disparities. Using federal patient-level quality data, researchers found that "many hospitals treat Whites and minorities equitably" but they noted that since many minorities tend to seek care at hospitals that "perform poorly on common quality score composites, the pay for performance efforts could unintentionally penalize hospitals serving high numbers of minorities.
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
› Verified 8 days ago
| Entity Name | Anesthesia Associates Of Columbus Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740251248 PECOS PAC ID: 6901701135 Enrollment ID: O20031202000054 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published in the July 22, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Angiotech Pharmaceuticals, Inc. today announced that its subsidiary, Angiotech Pharmaceuticals, Inc., has executed a Settlement and License Termination Agreement with Rex Medical, LP, providing for the full and final settlement and/or dismissal of all claims arising under the the License, Supply, Marketing and Distribution Agreement between Angiotech US and Rex, dated March 13, 2008.
Researchers wondered if pay-for-performance (P4P) programs, which reward hospitals for meeting quality targets, have unintentional effects on racial and/or ethnic disparities. Using federal patient-level quality data, researchers found that "many hospitals treat Whites and minorities equitably" but they noted that since many minorities tend to seek care at hospitals that "perform poorly on common quality score composites, the pay for performance efforts could unintentionally penalize hospitals serving high numbers of minorities.
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
› Verified 8 days ago
| Entity Name | Concordia Anesthesiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619296464 PECOS PAC ID: 8325172885 Enrollment ID: O20100819000220 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published in the July 22, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Angiotech Pharmaceuticals, Inc. today announced that its subsidiary, Angiotech Pharmaceuticals, Inc., has executed a Settlement and License Termination Agreement with Rex Medical, LP, providing for the full and final settlement and/or dismissal of all claims arising under the the License, Supply, Marketing and Distribution Agreement between Angiotech US and Rex, dated March 13, 2008.
Researchers wondered if pay-for-performance (P4P) programs, which reward hospitals for meeting quality targets, have unintentional effects on racial and/or ethnic disparities. Using federal patient-level quality data, researchers found that "many hospitals treat Whites and minorities equitably" but they noted that since many minorities tend to seek care at hospitals that "perform poorly on common quality score composites, the pay for performance efforts could unintentionally penalize hospitals serving high numbers of minorities.
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
› Verified 8 days ago
| Entity Name | Sentry Anesthesia Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134544794 PECOS PAC ID: 9436372323 Enrollment ID: O20140521002571 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published in the July 22, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Angiotech Pharmaceuticals, Inc. today announced that its subsidiary, Angiotech Pharmaceuticals, Inc., has executed a Settlement and License Termination Agreement with Rex Medical, LP, providing for the full and final settlement and/or dismissal of all claims arising under the the License, Supply, Marketing and Distribution Agreement between Angiotech US and Rex, dated March 13, 2008.
Researchers wondered if pay-for-performance (P4P) programs, which reward hospitals for meeting quality targets, have unintentional effects on racial and/or ethnic disparities. Using federal patient-level quality data, researchers found that "many hospitals treat Whites and minorities equitably" but they noted that since many minorities tend to seek care at hospitals that "perform poorly on common quality score composites, the pay for performance efforts could unintentionally penalize hospitals serving high numbers of minorities.
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frederick Oehrlein, MD Po Box 235019, Montgomery, AL 36123-5019 Ph: (334) 279-1450 | Dr Frederick Oehrlein, MD 2122 Manchester Expy, Columbus, GA 31904-6878 Ph: (706) 596-4000 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published in the July 22, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Angiotech Pharmaceuticals, Inc. today announced that its subsidiary, Angiotech Pharmaceuticals, Inc., has executed a Settlement and License Termination Agreement with Rex Medical, LP, providing for the full and final settlement and/or dismissal of all claims arising under the the License, Supply, Marketing and Distribution Agreement between Angiotech US and Rex, dated March 13, 2008.
Researchers wondered if pay-for-performance (P4P) programs, which reward hospitals for meeting quality targets, have unintentional effects on racial and/or ethnic disparities. Using federal patient-level quality data, researchers found that "many hospitals treat Whites and minorities equitably" but they noted that since many minorities tend to seek care at hospitals that "perform poorly on common quality score composites, the pay for performance efforts could unintentionally penalize hospitals serving high numbers of minorities.
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
› Verified 8 days ago
Dr. Hares Akbary, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7351 Old Moon Rd, Columbus, GA 31909 Phone: 706-653-7000 Fax: 706-653-7800 | |
Christopher M Jones, MD10/05/1962 Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 616 19th St, Columbus, GA 31901 Phone: 706-494-4262 | |
Rajesh Arora, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1427 Fax: 706-660-2686 | |
Dr. Harold Jarrell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expy, Columbus, GA 31904 Phone: 706-596-4000 | |
Dr. Sidney Bedell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2067 Osprey Cove Dr, Columbus, GA 31904 Phone: 770-883-7660 Fax: 478-352-0095 | |
Shaun R. Williams, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 334-279-1450 Fax: 334-395-4110 | |
Dr. Sung Kyu Chang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7351 Old Moon Rd, Columbus, GA 31909 Phone: 706-653-7000 Fax: 706-653-7800 |